- by Abraham Heifets, co-founder and CEO of Atomwise originally posted on Medium In their cogent and insightful discussion about the different perspectives of Tech and Biotech investors, Drs. Shaywitz and Gibson make the implicit assumption that AI […]
Apply for the Artificial Intelligence Molecular Screening (AIMS) Awards Program The AIMS Award Program, started in 2017, is designed to support promising researchers with resources that will help advance their work. AIMS Awards target research […]
- by Stefan Schroedl, Head of Machine Learning at Atomwise Originally posted on Medium This post is intended for my fellow machine learning engineers who are curious about applications in medicine, biology, or chemistry, but without a prior formal […]
- by Stefan Schroedl, Head of Machine Learning at Atomwise Originally posted on Medium Introduction Having applied machine learning to search and advertising for many years, two years ago I was ready for a transition to something new. In particular, […]
In November, Atomwise published the first scientific paper about our technologies – AtomNet®: A Deep Convolutional Neural Network for Bioactivity Prediction in Structure-based Drug Discovery. This blog post is an introduction to that work for a […]